Publication | Closed Access

Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia

Metabolic SyndromeLipid DisorderDiabetes ManagementLipid MetabolismCardiovascular DiseaseNondiabetic PatientsDiabetesPharmacologyDiabetes MellitusMedicineCombined DyslipidemiaDyslipidemiaOxidative Stress